BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 10931100)

  • 1. Cranial radiotherapy of childhood brain tumours: growth hormone deficiency and its relation to the biological effective dose of irradiation in a large population based study.
    Schmiegelow M; Lassen S; Poulsen HS; Feldt-Rasmussen U; Schmiegelow K; Hertz H; Müller J
    Clin Endocrinol (Oxf); 2000 Aug; 53(2):191-7. PubMed ID: 10931100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dosimetry and growth hormone deficiency following cranial irradiation of childhood brain tumors.
    Schmiegelow M; Lassen S; Weber L; Poulsen HS; Hertz H; Müller J
    Med Pediatr Oncol; 1999 Dec; 33(6):564-71. PubMed ID: 10573581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A population-based study of thyroid function after radiotherapy and chemotherapy for a childhood brain tumor.
    Schmiegelow M; Feldt-Rasmussen U; Rasmussen AK; Poulsen HS; Müller J
    J Clin Endocrinol Metab; 2003 Jan; 88(1):136-40. PubMed ID: 12519842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolution of growth hormone neurosecretory disturbance after cranial irradiation for childhood brain tumours: a prospective study.
    Spoudeas HA; Hindmarsh PC; Matthews DR; Brook CG
    J Endocrinol; 1996 Aug; 150(2):329-42. PubMed ID: 8869599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone releasing hormone plus arginine stimulation testing in young adults treated in childhood with cranio-spinal radiation therapy.
    Ham JN; Ginsberg JP; Hendell CD; Moshang T
    Clin Endocrinol (Oxf); 2005 May; 62(5):628-32. PubMed ID: 15853837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the hypothalamo-pituitary-adrenal axis in patients treated with radiotherapy and chemotherapy for childhood brain tumor.
    Schmiegelow M; Feldt-Rasmussen U; Rasmussen AK; Lange M; Poulsen HS; Müller J
    J Clin Endocrinol Metab; 2003 Jul; 88(7):3149-54. PubMed ID: 12843158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring serum insulin-like growth factor-I (IGF-I), IGF binding protein-3 (IGFBP-3), IGF-I/IGFBP-3 molar ratio and leptin during growth hormone treatment for disordered growth.
    Tillmann V; Patel L; Gill MS; Whatmore AJ; Price DA; Kibirige MS; Wales JK; Clayton PE
    Clin Endocrinol (Oxf); 2000 Sep; 53(3):329-36. PubMed ID: 10971450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone response to a growth hormone-releasing hormone stimulation test in a population-based study following cranial irradiation of childhood brain tumors.
    Schmiegelow M; Lassen S; Poulsen HS; Feldt-Rasmussen U; Schmiegelow K; Hertz H; Müller J
    Horm Res; 2000; 54(2):53-9. PubMed ID: 11251367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum IGF-I and IGFBP-3 concentrations do not accurately predict growth hormone deficiency in children with brain tumours.
    Weinzimer SA; Homan SA; Ferry RJ; Moshang T
    Clin Endocrinol (Oxf); 1999 Sep; 51(3):339-45. PubMed ID: 10469014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IGF-I and IGF binding protein-3 levels during initial GH dosage step-up are indicators of GH sensitivity in GH-deficient children and short children born small for gestational age.
    Ranke MB; Traunecker R; Martin DD; Schweizer R; Schwarze CP; Wollmann HA; Binder G
    Horm Res; 2005; 64(2):68-76. PubMed ID: 16113581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between the growth hormone and insulin-like growth factor axis in long-term survivors of childhood brain tumours.
    Achermann JC; Hindmarsh PC; Brook CG
    Clin Endocrinol (Oxf); 1998 Nov; 49(5):639-45. PubMed ID: 10197080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gonadal status in male survivors following childhood brain tumors.
    Schmiegelow M; Lassen S; Poulsen HS; Schmiegelow K; Hertz H; Andersson AM; Skakkebaek NE; Müller J
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2446-52. PubMed ID: 11397837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The diagnosis of severe growth hormone deficiency in elderly patients with hypothalamic-pituitary disease.
    Toogood AA; Jones J; O'Neill PA; Thorner MO; Shalet SM
    Clin Endocrinol (Oxf); 1998 May; 48(5):569-76. PubMed ID: 9666868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Height velocity and IGF-I assessment in the diagnosis of childhood onset GH insufficiency: do we still need a second GH stimulation test?
    Cianfarani S; Tondinelli T; Spadoni GL; Scirè G; Boemi S; Boscherini B
    Clin Endocrinol (Oxf); 2002 Aug; 57(2):161-7. PubMed ID: 12153594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone (GH) provocative retesting of 108 young adults with childhood-onset GH deficiency and the diagnostic value of insulin-like growth factor I (IGF-I) and IGF-binding protein-3.
    Juul A; Kastrup KW; Pedersen SA; Skakkebaek NE
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1195-201. PubMed ID: 9100596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influences on quality of life in GH deficient adults and their effect on response to treatment.
    Murray RD; Skillicorn CJ; Howell SJ; Lissett CA; Rahim A; Smethurst LE; Shalet SM
    Clin Endocrinol (Oxf); 1999 Nov; 51(5):565-73. PubMed ID: 10594517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Low sensitivity of IGF-I, IGFBP-3 and urinary GH in the diagnosis of growth hormone insufficiency in slowly-growing short-statured boys. Grupo Español de Estudio de la Talla Baja].
    Audí L; Antonia Llopis M; Luisa Granada M; Hermoso F; del Valle J; Dolores Rodríguez-Arnao M; Bel J; Luzuriaga C; Gallego E; Marín F;
    Med Clin (Barc); 2001 Jan; 116(1):6-11. PubMed ID: 11181253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of the outcome of growth hormone provocative testing in short children by measurement of serum levels of insulin-like growth factor I and insulin-like growth factor binding protein 3.
    Juul A; Skakkebaek NE
    J Pediatr; 1997 Feb; 130(2):197-204. PubMed ID: 9042120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma levels of insulin-like binding protein-2 in prepubertal short children and its diagnostic value in the evaluation of growth hormone deficiency.
    van Doorn J; Ringeling AM; Rikken B; van Buul-Offers SC
    Horm Res; 2001; 55(3):147-54. PubMed ID: 11549877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation dose-volume effects on growth hormone secretion.
    Merchant TE; Goloubeva O; Pritchard DL; Gaber MW; Xiong X; Danish RK; Lustig RH
    Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1264-70. PubMed ID: 11955738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.